| Nome |
# |
|
HERG K+ channels and β1 integrins interact through the assembly of a macromolecular complex, file 3a6c4897-9316-4443-937e-2631c0dde418
|
502
|
|
The conformational state of hERG1 channels determines integrin association, downstream signaling, and cancer progression, file e398c37b-d759-179a-e053-3705fe0a4cff
|
440
|
|
HERG potassium channels are constitutively expressed in primary human acute myeloid leukemias and regulate cell proliferation of normal and leukemic hemopoietic progenitors, file e398c378-93ef-179a-e053-3705fe0a4cff
|
268
|
|
Ivosidenib in IDH1-mutated cholangiocarcinoma: Clinical evaluation and future directions, file 59250bc1-0a9d-40ef-bc34-451777c0627c
|
263
|
|
Aflibercept plus folfiri as second-line treatment for metastatic colorectal cancer: A single-institution real-life experience, file 795c501b-bca5-4723-9583-b1579276acab
|
201
|
|
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug, file e398c37b-2be7-179a-e053-3705fe0a4cff
|
168
|
|
hLH/hCG-receptor expression correlates with in vitro invasiveness in human primary endometrial cancer, file e398c37f-25b9-179a-e053-3705fe0a4cff
|
163
|
|
hERG1 Channels Regulate VEGF-A Secretion in Human Gastric Cancer: Clinicopathological Correlations and Therapeutical Implications, file e398c37b-0cd4-179a-e053-3705fe0a4cff
|
153
|
|
Circulating Endothelial Progenitor Cells in Type 1 Diabetic Patients: Relation with Patients' Age and Disease Duration., file e398c37c-a508-179a-e053-3705fe0a4cff
|
131
|
|
Anticancer effects against colorectal cancer models of chloro(triethylphosphine)gold(I) encapsulated in PLGA–PEG nanoparticles, file e398c381-42cf-179a-e053-3705fe0a4cff
|
123
|
|
Ion Channels in Hematopoietic and Mesenchymal Stem Cells, file e398c37a-5ecf-179a-e053-3705fe0a4cff
|
122
|
|
Engineering l-asparaginase for spontaneous formation of calcium phosphate bioinspired microreactors., file e398c37d-8477-179a-e053-3705fe0a4cff
|
107
|
|
Severe hypoxia selects hematopoietic progenitors with stem cell potential from primary Myelodysplastic syndrome bone marrow cell cultures., file e398c37d-b2f7-179a-e053-3705fe0a4cff
|
105
|
|
Circulating miRNome profiling data in Behçet's syndrome, file e398c381-7b84-179a-e053-3705fe0a4cff
|
105
|
|
Irresponsiveness of two retinoblastoma cases to conservative therapy correlates with up- regulation of hERG1 channels and of the VEGF-A pathway., file e398c378-bbc0-179a-e053-3705fe0a4cff
|
104
|
|
Peptides and small molecules blocking the CXCR4/CXCL12 axis overcome bone marrow-induced chemoresistance in acute leukemias, file e398c37f-e262-179a-e053-3705fe0a4cff
|
93
|
|
The ion channels and transporters gene expression profile indicates a shift in excitability and metabolisms during malignant progression of Follicular Lymphoma, file e398c380-33a2-179a-e053-3705fe0a4cff
|
93
|
|
Chasing the target: New phenomena of resistance to novel selective ret inhibitors in lung cancer. updated evidence and future perspectives, file e398c381-c65a-179a-e053-3705fe0a4cff
|
89
|
|
Data describing the effects of the Macrolide Antibiotic Clarithromycin on preclinical mouse models of Colorectal Cancer, file e398c37f-3275-179a-e053-3705fe0a4cff
|
88
|
|
A Machine Learning Decision Support System (DSS) for Neuroendocrine Tumor Patients Treated with Somatostatin Analog (SSA) Therapy, file e398c381-6307-179a-e053-3705fe0a4cff
|
82
|
|
Association of systemic steroid treatment and outcome in patients treated with immune checkpoint inhibitors: A real-world analysis, file b927e36e-7fc7-4d00-952e-2023fb3e96ef
|
70
|
|
LH/hCG-Receptor Expression May Have a Negative Prognostic Value in Low-Risk Endometrial Cancer, file e398c37a-aa0c-179a-e053-3705fe0a4cff
|
66
|
|
Transgenic mice overexpressing the LH receptor in the female reproductive system spontaneously develop endometrial tumour masses, file e398c381-2e55-179a-e053-3705fe0a4cff
|
61
|
|
Pilot investigation of the mutation profile of PIK3CA/PTEN genes (PI3K pathway) in grade 3 endometrial cancer, file e398c380-2c54-179a-e053-3705fe0a4cff
|
60
|
|
Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer, file eaa8ac77-b63d-4973-9b71-95585690e0a4
|
60
|
|
Somatostatin analogs in pregnant patients with neuroendocrine tumor, file 488cbb9c-29ea-417a-b090-f1465cd91e18
|
57
|
|
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing, file 3642495f-1b69-4e78-8518-99fcc78cc0bb
|
48
|
|
Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer, file e398c380-bc6a-179a-e053-3705fe0a4cff
|
43
|
|
Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy, file 9b9ef512-b36d-44f9-ae2c-83656d8b1804
|
40
|
|
Insights into the structure/function of hepatocyte growth factor/scatter factor from studies with individual domains, file e0a50e97-54d6-4340-895d-aa3f7f7d7eeb
|
37
|
|
Structural and solution chemistry, antiproliferative effects, and serum albumin binding of three pseudohalide derivatives of auranofin, file 5932ca7c-b737-41ed-aced-6d139a967772
|
33
|
|
New compositions of the treatment of chemoresistant and/or potentially chemoresistant leukemias, file e398c378-cbee-179a-e053-3705fe0a4cff
|
32
|
|
New gold carbene complexes as candidate anticancer agents, file 3655acb3-b83f-4748-b72d-2e39d5465a70
|
25
|
|
Association between Immune Related Adverse Events and Outcome in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors, file b9a6189c-e6e8-4bea-ad70-40ccf94873d5
|
21
|
|
Safety of Immune Checkpoint Inhibitors in Elderly Patients: An Observational Study, file ca076d7d-0b30-4a20-a790-48ba1c4fdd2a
|
21
|
|
Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study, file b548539b-0955-4439-bb6b-9f0aa189e572
|
19
|
|
Antiproliferative properties and biomolecular interactions of three Pd(II) and Pt(II) complexes, file cbc96a85-679f-4d11-a6c6-2bbae1e8e40a
|
19
|
|
Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic Cancer (NabucCO Study), file e61277c8-c13c-48bc-9ef6-dd4aa9dead10
|
16
|
|
New compositions of the treatment of chemoresistant and/or potentially chemoresistant leukemias, file e398c378-cc51-179a-e053-3705fe0a4cff
|
15
|
|
Identification of Non-Cardiotoxic hERG1 Blockers to Overcome Chemoresistance in Acute Lymphoblastic Leukemias, file 4e2a15cb-b967-43de-98e0-01ad58c22f13
|
14
|
|
Potent in vitro antiproliferative properties for a triplatinum cluster toward triple negative breast cancer cells, file 583ae5d1-7d51-49bd-affc-84591ec9804e
|
11
|
|
Immune checkpoint inhibitors in the treatment of renal cancer: Current state and future perspective, file 7ef91b72-6e41-4cd4-96a2-f15f02e05cc6
|
11
|
|
Practical tips and new trends in electrochemical biosensing of cancer-related extracellular vesicles, file e001b2ec-b19e-452b-8b46-bb1262d146fa
|
11
|
|
hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer, file 4b7c9f3e-7256-463f-8503-b6503d1b96ab
|
10
|
|
Overcoming Chemotherapy Resistance in Childhood Acute Lymphoblastic Leukemia by Targeting Ion Channels., file 2c852df2-2939-4367-82e5-09f5600e020d
|
9
|
|
Pharmacogenomics of soft tissue sarcomas: New horizons to understand efficacy and toxicity, file 63641d27-ced3-4b1d-9e1e-f2636e4720a7
|
9
|
|
ROS1 rearrangements are uncommon in biliary tract cancers, file cf424955-6c10-4861-b8d0-2db10f22157d
|
9
|
|
Design, synthesis and characterisation of new chimeric ruthenium(ii)-gold(i) complexes as improved cytotoxic agents, file e398c382-33a5-179a-e053-3705fe0a4cff
|
9
|
|
c-Met oncogene enhances Fas-mediated apoptosis in B-ALL t(12;21) cells, file 2d832093-1f4d-43b0-ad3c-24bbc6647496
|
8
|
|
The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer, file 7d4e2577-3346-4dea-ac46-84412fa88dad
|
8
|
|
The emerging role of immunotherapy in biliary tract cancer: a review of new evidence and predictive biomarkers, file b1af915a-33ab-4336-be50-ceaa2470df47
|
8
|
|
Growth arrest-specific 5 lncRNA as a valuable biomarker of chemoresistance in osteosarcoma, file 1fff05f5-034d-442f-b68c-93111813d6be
|
7
|
|
Systemic Sclerosis Association with Malignancy, file b3f911bf-019f-4b17-a3da-0e8ba173043d
|
7
|
|
Luteinizing Hormone/Human Chorionic Gonadotropin Receptor Immunohistochemical Score Associated with Poor Prognosis in Endometrial Cancer Patients., file 658bfc07-395a-449a-82ed-6efc77f66b2b
|
6
|
|
Results of the observational prospective RealFLOT study, file 766c0e2b-ef12-4d4c-9811-5c44a4a5534e
|
6
|
|
Immune checkpoint blockade with anti-programmed cell death 1 (PD-1) monoclonal antibody (mAb) cemiplimab: ongoing and future perspectives in rare genital cancers treatment, file 0e498886-161d-4f1f-9ca8-037b979d22e8
|
5
|
|
Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer, file 8bbbaf25-d6dc-4398-b7e6-eb28870c31de
|
5
|
|
The combined activation of K Ca 3.1 and inhibition of K v 11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells, file d445b411-c7cd-42a7-a84b-4f1410bc9f9d
|
4
|
|
Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients, file 07c42cd4-eadb-4a1b-82c1-68f0a13b7e80
|
3
|
|
Targeting KCa3.1 channels to overcome erlotinib resistance in non-small cell lung cancer cells, file 17981f43-e5ea-434b-a57c-53f9d258f26e
|
3
|
|
Bone Metastases in Renal Cell Carcinoma: Impact of Immunotherapy on Survival, file 3b5be3d6-7a7a-41fa-8f2f-d3ad094ce089
|
3
|
|
Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers., file e398c378-b488-179a-e053-3705fe0a4cff
|
3
|
|
Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers., file e398c378-b489-179a-e053-3705fe0a4cff
|
3
|
|
Soft tissue sarcoma: An insight on biomarkers at molecular, metabolic and cellular level, file ffa4547e-e43a-4391-90ae-9dfd396fe270
|
3
|
|
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing, file 30b73694-4fa3-4aef-aafd-75dac30b35ae
|
2
|
|
KRAS-related miR-143 expression is associated with lymph node involvement and correlates with outcome in pancreatic adenocarcinoma patients, file 3a8a5a93-5061-49d8-ab7b-549f4b77d28b
|
2
|
|
The increase of endothelial progenitor cells in the peripheral blood: a new parameter for detecting onset and severity of sepsis., file e398c378-a4a9-179a-e053-3705fe0a4cff
|
2
|
|
Identification of a posttranslational mechanism for the regulation of hERG1 K+ channel expression and hERG1 current density in tumor cells., file e398c378-ae2c-179a-e053-3705fe0a4cff
|
2
|
|
Alteration of the Nucleotide Excision Repair (NER) Pathway in Soft Tissue Sarcoma, file aa3e259e-260d-4655-abe9-a2f7e9aa661e
|
1
|
| Totale |
4.327 |